Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Comparison of urinary flow with two female intermittent catheters

Official title: Comparison of Urinary Flow Speed Using 14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter Versus 14 Fr Coloplast Micro Zone Luja Female Catheter in Female Patients Using Intermittent Catheters

Run by Wake Forest University Health Sciences · NCT06918067 · Data updated 2026-11-12

This test will see if two different female intermittent catheters produce different urinary flow speeds in adults who regularly catheterize.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment17 (estimated)
SponsorWake Forest University Health Sciences
Academic / other
Locations1 site (Charlotte, North Carolina)
StatusRecruiting
StartedNovember 6, 2025
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedMarch 5, 2026
Trial IDNCT06918067 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older who have been regularly using intermittent catheterization for at least one month and can attend a single in-person visit are ideal candidates.

Probably not a fit

People with severe urinary tract abnormalities, current urinary tract infection, recent surgery, pregnancy or breastfeeding, hypersensitivity to catheter ingredients, or inability to follow the procedures may not receive benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized crossover comparison of two 14 Fr female catheters made by Coloplast, the Two Eyelet SpeediCath and the Micro Zone Luja. Participants are randomly assigned to one of two sequences, self-catheterize with the first device, have the bladder backfilled with sterile fluid equal to the urine collected, then self-catheterize with the second device. Urinary flow outcomes are measured during a single office visit using an uroflowmetry device, and participants receive a follow-up phone call about one week later. The crossover design lets each participant serve as her own control to compare flow speed between the two catheters.

Why it matters

Potential benefit: If successful, the results could help people who catheterize choose a catheter that empties the bladder faster or more efficiently.

How similar studies have gone: Prior crossover comparisons of catheter designs have been performed and sometimes show small differences in flow or usability, so this approach builds on modest prior evidence rather than being entirely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female
* Regular use of intermittent catheters to empty bladder, for at least 1 month before enrolment
* Age 18 years or older
* Required to adhere to the intervention procedure and not participate in any other clinical studies throughout the duration of this study

Exclusion Criteria:

* Severe urinary tract abnormalities (e.g. excessive production of urinary mucus/sediments/debris)
* Hypersensitive to the ingredients in the catheters being tested
* Recent surgery, within 3 months
* Currently being treated for urinary tract infection
* Being pregnant or breastfeeding
* Non-English speaking

Where it's running

  • Women's Center for Pelvic Health (Mercy)
    Charlotte, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.